• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Extracorporeal Blood Purification Is Appropriate in Critically Ill Patients with COVID-19 and Multiorgan Failure: CON.

作者信息

Kashani Kianoush, Forni Lui G

机构信息

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.

出版信息

Kidney360. 2021 Aug 19;3(3):419-422. doi: 10.34067/KID.0007382020. eCollection 2022 Mar 31.

DOI:10.34067/KID.0007382020
PMID:35582178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9034827/
Abstract
摘要

相似文献

1
Extracorporeal Blood Purification Is Appropriate in Critically Ill Patients with COVID-19 and Multiorgan Failure: CON.体外血液净化适用于患有新冠肺炎和多器官功能衰竭的重症患者：反对观点。
Kidney360. 2021 Aug 19;3(3):419-422. doi: 10.34067/KID.0007382020. eCollection 2022 Mar 31.
2
Extracorporeal Blood Purification Is Appropriate in Critically Ill Patients with COVID-19 and Multiorgan Failure: PRO.体外血液净化适用于患有新冠肺炎和多器官功能衰竭的危重症患者：正方观点。
Kidney360. 2021 Aug 19;3(3):416-418. doi: 10.34067/KID.0006632020. eCollection 2022 Mar 31.
3
Extracorporeal Blood Purification Is Appropriate in Critically Ill Patients with COVID-19 and Multiorgan Failure: COMMENTARY.体外血液净化适用于患有新冠肺炎和多器官功能衰竭的危重症患者：评论
Kidney360. 2021 Aug 19;3(3):423-425. doi: 10.34067/KID.0005242021. eCollection 2022 Mar 31.
4
Hemoperfusion as a Potential Treatment for Critically Ill COVID-19 Patients with Cytokine Storm.血液灌流作为治疗重症新冠病毒肺炎细胞因子风暴患者的潜在疗法
Blood Purif. 2021;50(3):405-407. doi: 10.1159/000511391. Epub 2020 Nov 10.
5
Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.选择合适的对照组对于评估 COVID-19 中的细胞因子风暴至关重要。
In Vivo. 2021 Mar-Apr;35(2):1295-1298. doi: 10.21873/invivo.12381.
6
Application of extracorporeal therapies in critically ill COVID-19 patients.体外治疗在危重症 COVID-19 患者中的应用。
J Zhejiang Univ Sci B. 2021;22(9):701-717. doi: 10.1631/jzus.B2100344.
7
Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation.《COVID-19 大流行期间危重症患者的体外血液净化和器官支持：专家综述和推荐》
Blood Purif. 2021;50(1):17-27. doi: 10.1159/000508125. Epub 2020 May 26.
8
Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options.SARS-CoV-2 诱导的细胞因子风暴在多器官衰竭中的作用：分子途径和潜在的治疗选择。
Int Immunopharmacol. 2022 Dec;113(Pt B):109428. doi: 10.1016/j.intimp.2022.109428. Epub 2022 Nov 7.
9
The association between therapeutic plasma exchange and the risk of mortality among patients critically ill with COVID-19: a meta-analysis.治疗性血浆置换与 COVID-19 危重症患者死亡率之间的关联：一项荟萃分析。
F1000Res. 2021 Dec 14;10:1280. doi: 10.12688/f1000research.74972.1. eCollection 2021.
10
Therapeutic plasma exchange in a critically ill Covid-19 patient.危重症 COVID-19 患者的治疗性血浆置换。
J Clin Apher. 2021 Feb;36(1):179-182. doi: 10.1002/jca.21830. Epub 2020 Sep 1.

引用本文的文献

1
Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the liquid biopsy.通过液体活检确定ExThera Seraph100血液过滤对诊断为胰腺癌患者的疗效。
BJC Rep. 2024 Jun 27;2(1):47. doi: 10.1038/s44276-024-00069-3.
2
Efficacy of additional hemoperfusion in hospitalized patients with severe to critical COVID-19 disease.住院的重症至危重症 COVID-19 患者行血液灌流治疗的疗效。
Sci Rep. 2024 Jul 31;14(1):17651. doi: 10.1038/s41598-024-68592-4.
3
Haemoadsorption Combined with Continuous Renal Replacement Therapy in Abdominal Sepsis: Case Report Series.血液吸附联合连续性肾脏替代疗法治疗腹部脓毒症：病例系列报道
J Pers Med. 2023 Jul 10;13(7):1113. doi: 10.3390/jpm13071113.